These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 8390160)
1. The potential of melanotropins in the treatment of nervous system diseases. Gispen WH Ann N Y Acad Sci; 1993 May; 680():401-11. PubMed ID: 8390160 [No Abstract] [Full Text] [Related]
2. On the neurotrophic action of melanocortins. Gispen WH; De Koning P; Kuiters RR; Van der Zee CE; Verhaagen J Prog Brain Res; 1987; 72():319-31. PubMed ID: 3039580 [No Abstract] [Full Text] [Related]
3. Pharmacological aspects of the influence of melanocortins on the formation of regenerative peripheral nerve sprouts. Verhaagen J; Edwards PM; Jennekens FG; Gispen WH Peptides; 1987; 8(4):581-4. PubMed ID: 2819831 [TBL] [Abstract][Full Text] [Related]
4. Natriuretic and hypertensinogenic pro-opiomelanocortin derived peptides. Gruber KA; Callahan MF; Kirby RF; Johnson AK; Lymangrover JR Regul Pept Suppl; 1985; 4():118-23. PubMed ID: 2997849 [No Abstract] [Full Text] [Related]
5. Electrophysiological effects of peptides derived from pro-opiomelanocortin. Urban IJ Pharmacol Ther; 1984; 24(1):57-90. PubMed ID: 6328550 [No Abstract] [Full Text] [Related]
6. Dorsal root ganglia as an in vitro model for melanocortin-induced neuritogenesis. Pharmacological and mechanistic aspects. Hol EM; Sodaar P; Bär PR Ann N Y Acad Sci; 1994 Oct; 739():74-86. PubMed ID: 7832498 [No Abstract] [Full Text] [Related]
8. ACTH (4-10) increases quantal content at the mouse neuromuscular junction. Davies DA; Smith ME Brain Res; 1994 Feb; 637(1-2):328-30. PubMed ID: 8180813 [TBL] [Abstract][Full Text] [Related]
9. Trophic effects of melanocortins on neuronal cells in culture. Bär PR; Hol EM; Gispen WH Ann N Y Acad Sci; 1993 Aug; 692():284-6. PubMed ID: 8215033 [No Abstract] [Full Text] [Related]
10. LPH, ACTH, MSH and motor systems. Strand FL; Smith CM Pharmacol Ther; 1980; 11(3):509-33. PubMed ID: 6255499 [No Abstract] [Full Text] [Related]
11. Melanotropins as growth factors. Strand FL; Zuccarelli LA; Williams KA; Lee SJ; Lee TS; Antonawich FJ; Alves SE Ann N Y Acad Sci; 1993 May; 680():29-50. PubMed ID: 8390155 [TBL] [Abstract][Full Text] [Related]
13. Effect of N-terminal portion of pro-opiomelanocortin on aldosterone release by human adrenal adenoma in vitro. Lis M; Hamet P; Gutkowska J; Maurice G; Seidah NG; Larivière N; Chrétien M; Genest J J Clin Endocrinol Metab; 1981 Jun; 52(6):1053-6. PubMed ID: 6262359 [TBL] [Abstract][Full Text] [Related]
14. Natriuretic peptides derived from pro-opiocortin. Gruber KA; Klein MC; Lymangrover JR Prog Clin Biol Res; 1985; 192():213-20. PubMed ID: 3001754 [TBL] [Abstract][Full Text] [Related]
15. A possible role for intermediate lobe peptides in the pathogenesis of idiopathic aldosteronism. Mulrow PJ Trans Am Clin Climatol Assoc; 1984; 95():26-33. PubMed ID: 6089399 [No Abstract] [Full Text] [Related]
16. Melanocortins, neural plasticity and aging. Gispen WH; Isaacson RL; Spruijt BM; de Wied D Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):415-26. PubMed ID: 3025925 [TBL] [Abstract][Full Text] [Related]
17. Experimentally-induced autonomic neuropathy: beneficial effect of a topical ACTH4-9 analogue on oculomotor nerve regeneration. Vandertop WP; de Vries WB; Notermans NC; Tulleken CA; Gispen WH Neurosurgery; 1994 Sep; 35(3):457-61; discussion 462. PubMed ID: 7800137 [TBL] [Abstract][Full Text] [Related]
18. Rationale for the use of the ACTH4-9 analogue ORG 2766 in the treatment of diabetic neuropathy. Bravenboer B; Erkelens DW; Gispen WH Neth J Med; 1992 Dec; 41(5-6):255-8. PubMed ID: 1337372 [No Abstract] [Full Text] [Related]